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We present a new, power-free and ﬂexible detection system named MCFphone for portable colorimetric
and ﬂuorescence quantitative sandwich immunoassay detection of prostate speciﬁc antigen (PSA). The
MCFphone is composed by a smartphone integrated with a magnifying lens, a simple light source and a
miniaturised immunoassay platform, the Microcapillary Film (MCF). The excellent transparency and ﬂat
geometry of ﬂuoropolymer MCF allowed quantitation of PSA in the range 0.9 to 60 ng/ml witho7%
precision in 13 min using enzymatic ampliﬁcation and a chromogenic substrate. The lower limit of de-
tection was further improved from 0.4 to 0.08 ng/ml in whole blood samples with the use of a ﬂuor-
escence substrate. The MCFphone has shown capable of performing rapid (13 to 22 min total assay time)
colorimetric quantitative and highly sensitive ﬂuorescence tests with good %Recovery, which represents
a major step in the integration of a new generation of inexpensive and portable microﬂuidic devices with
commercial immunoassay reagents and off-the-shelf smartphone technology.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Decentralisation of diagnostic testing to near the patient sites is
both a trend and a need in clinical diagnostics. Immunoassay
platforms (the most common laboratory bioanalytical tool) and
detection systems must therefore be adapted for point of care
(POC) testing, which requires the ability to design affordable,
portable, and user-friendly immunoassay systems capable of rapid
and sensitive detection using well established immunoassay che-
mistries (von Lode, 2005).
Diagnostic tests are routinely used to diagnose and select
treatment options for many critical health conditions, including
cardiovascular diseases, sepsis, ovarian and prostate cancer, de-
mand quantitation of one or multiple analytes (Altintas et al.,
2014; Coelho and Martins, 2012; Loeb and Catalona, 2007; Zhang
et al., 2011). Agglutination and lateral ﬂow assays are the most
widely used POC immunoassay tests, however these formats are
usually qualitative or semi-quantitative, lacking both the sensi-
tivity for many important biomarkers and the ability to perform
multiplex analysis (von Lode, 2005). This has driven ther B.V. This is an open access article
l Engineering, Loughborough
. Fax: þ44 0 1509 223 923.development of microﬂuidic immunoassay platforms (Gervais
et al., 2011), combining minimal diffusion distances and high
surface-area-to-volume ratios for improved performance, with the
use microchannels or beads for rapid and sensitive detection of
analytes from small sample volumes (Gervais and Delamarche,
2009; Ikami et al., 2010; Park et al., 2012).
Optical detection is often preferred in POC testing, as it can
rapidly and simply provide high-resolution microscopic and
macroscopic information (Pierce et al., 2014; Zhu et al., 2013). The
recent fall in cost of optoelectronic components now offers cost
beneﬁts for portable detection systems. Two most common optical
detection techniques used in microﬂuidic immunoassays are
ﬂuorescence and chemiluminescence, due to their excellent sen-
sitivity (Lin et al., 2010). However, the readout equipment used to
detect these signals is complex and expensive, typically requiring a
ﬂuorescence or confocal microscope or high-sensitivity optical
sensors, and therefore not portable or cost-effective for POC use
(Myers and Lee, 2008). The opportunity for using simple portable
optical detection in microﬂuidic diagnostics has recently arisen
because of the rapid expansion in consumer electronics such as
high-performance smartphones cameras that are now ubiquitous,
and have driven down the price of high performance digital image
sensors combined with portable computers (Zhu et al., 2013).
Smartphones are portable, widely available, user-friendly and low
cost, and are therefore suitable for integration into a microﬂuidicunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Examples of microﬂuidic diagnostic tests based on smartphone
measurement include colorimetric detection of Salmonella from an
immunoagglutination assay (Park et al., 2013); measurement of
urine, saliva and sweat pH (Erickson et al., 2014; Shen et al., 2012);
quantitation of vitamin D measured using a competitive lateral
ﬂow immunoassay (Lee et al., 2014); and prostate speciﬁc antigen
(PSA) quantitation from a sandwich microﬂuidic immunoassay
with a lower limit of detection (LoD) of 3.2 ng/ml PSA in serum
samples (Adel Ahmed and Azzazy, 2013). Most smartphone de-
tection systems reported so far are based on colorimetric detection
(Oncescu et al., 2013). Although colorimetric detection is usually
more cost-effective, easy-to-use and rapid (Lin et al., 2010),
ﬂuorescence detection should present higher sensitivity for
quantitative POC diagnostics, allowing low analyte cut off values in
small sample volumes which is vital for many clinical biomarkers.
Smartphone ﬂuorescence detection has been reported in some
bioassays, such as quantiﬁcation of albumin using a dye based
assay (Coskun et al., 2013), in a lateral ﬂow assay (Lee et al., 2013)
and ﬁnally to detect bacteria using a lateral ﬂow assay with
ﬂuorescence nanoparticles (Rajendran et al., 2014). However,
smartphone ﬂuorescence detection has not yet been reported in
sandwich ELISA systems for accurate quantitation of analytes, and
this would bring POC microﬂuidic diagnostics to a new level of
portability and sensitivity.
In this study we present a ﬂexible smartphone based colori-
metric and ﬂuorescence detection system, termed the MCFphone,
capable of detecting PSA from whole blood in the relevant clinical
range in 13 min using colorimetric detection and 22 min using
ﬂuorescence detection. PSA is the mostly widely used prostate
cancer biomarker, and continuous monitoring of PSA levels in
patients with prostate cancer is a vital diagnostic tool. PSA blood
levels determination in conjugation with digital rectal examina-
tion was approved by the Food and Drugs Administration to test
asymptomatic men aged 50 year old with a cut off value of 4 ng/ml
of PSA (De Angelis et al., 2007; Institute, 2012). Many studies
suggested that prostate cancer mortality can be decreased by early
detection, and so screening programs have been proposed utilising
PSA quantitation in blood. We propose that a quantitative whole
blood PSA sandwich assay in a rapid, sensitive, and portable test
device would allow POC prostate cancer monitoring and screening
even in remote areas of developing countries where laboratory
facilities are limited. The MCFphone detection system could easily
be combined with the “Lab-in-a-briefcase” assay platform re-
ported recently (Barbosa et al., 2014), replacing the ﬂatbed scanner
readout system and increasing portability, ﬂexibility and
sensitivity.2. Materials and methods
2.1. Materials and reagents
Enzymatic chromogenic and ﬂuorescence products 2,3-diami-
nophenazine (DAP) and ﬂuorescein isothiocyanate (FITC), dimethyl
sulfoxide (DMSO), streptavidin alkaline phosphatase, SIGMA-
FASTTM OPD (o-Phenylenediamine dihydrochloride) tablets and
FDP (ﬂuorescein diphosphate) were sourced from Sigma-Aldrich
(Dorset, UK). High sensitivity streptavidin-HRP was supplied by
Thermo Scientiﬁc (Lutterworth, UK).
Human kallikrein 3/ Prostate Speciﬁc Antigen (PSA) ELISA kit
was purchased from R&D Systems (Minneapolis, USA). The kit
contained a monoclonal mouse Human Kallikrein 3/PSA antibody
(capture antibody), a Human Kallikrein 3/PSA polyclonal biotyni-
lated antibody (detection antibody) and recombinant Human
Kallikrein 3/PSA (standard). Phosphate buffered solution (PBS) andBovine Serum Albumin (BSA) were sourced from Sigma Aldrich,
Dorset, UK. PBS pH 7.4, 10 mM was used as the main immunoassay
buffer. Carbonate buffer 50 mM pH 8 and Tris Buffer 50 mM pH
9.2 were used for ﬂuorescence detection with alkaline phospha-
tase. The blocking solution consisted in 3% w/v protease-free BSA
diluted in PBS buffer. For washings, PBS with 0.05% v/v of Tween-
20 (Sigma-Aldrich, Dorset, UK) was used. The whole blood used
was obtained from donation system at Loughborough University,
Sports Department, and collected into 5 ml tubes with citrate
phosphate as anticoagulant.
The MicroCapillary Film (MCF) platform is fabricated from
ﬂuorinated ethylene propylene co-polymer (FEP-Teﬂons) by melt-
extrusion process by Lamina Dielectrics Ltd. (Billinghurst, West
Sussex, UK). The number and internal diameter of the micro-
capillaries is easily controlled by the design of the die and the
operational conditions set during the continuous melt-extrusion
process. The two primary light sources used include an Auraglow
AG166 Blue LED bulb, from Argos UK and an Ultraviolet Mini
Lantern UV Fluorescent purchased from Mapplin UK. A 60x mag-
niﬁcation attachment for iPhones 4/4S purchased from Amazon
(Slough, Berkshire) and a 50 mm square dichroic additive green
ﬁlter sourced from Edmund Optics (York, UK).
2.2. MCFphone – system overview
The MCFphone detection system is composed by a 10 bore
ﬂuoropolymer MCF strips pre-coated with immobilized capture
antibody and blocked with BSA protein (1), smartphone (iPhones
4S, 8 megapixels camera) (2) integrated magnifying lens (3), light
source (blue LED, with peak wavelength of 450 nm for chromo-
genic detection) (4), or UV black light for ﬂuorescence detection
(5), and a dichroic additive green ﬁlter (6) for ﬂuorescence de-
tection (Fig. 1A).
The MCF used consisted of a ﬂuoropolymer melt-extruded
plastic ﬁlm with 10 embedded parallel microcapillaries and a
mean 200 mm internal diameter. Each strip has 4.5 70.1 mm
width and 0.670.05 mm depth (Fig. 1B). This platform was ﬁrst
presented as a cost-effective microﬂuidic immunoassay platform
by Edwards et al. (2011); the hydrophobicity of FEP material allows
simple yet effective immobilisation of antibodies by passive ad-
sorption on the plastic surface of the microcapillaries, and the
transparency of the MCF material results in high signal-to-noise
ratios (Edwards et al., 2011) which is fundamental for sensitive
signal quantitation.
The MCFphone working principle consists in illuminating the
MCF test strip sample with a light source (blue LED for chromo-
genic detection and UV black light for ﬂuorescence detection) and
capturing the signal (digital image) with a smartphone camera
attached with a magnifying lens (Fig. 1C). The digital images were
then analysed with Image J software (NIH, Maryland, USA) for
colourimetric or ﬂuorescence signal quantitation.
2.3. PSA sandwich ELISA (enzyme linked immunosorbent assay)
2.3.1. Fabrication of MCF test strips
A solution of 40 mg/ml of Human Kallikrein 3/PSA capture an-
tibody in PBS buffer was aspirated into a 100 cm lengh MCF and
incubated for two hours at room temperature in a petri dish
covered with a wet tissue to avoid evaporation of solution in the
microcapillaries. A 3% BSA solution in PBS buffer was then aspi-
rated and incubated in the MCF for an additional two hours at
room temperature to block any additional binding sites in the
microcapillaries. The MCF strip was then washed with 0.05%
Tween in PBS, and stored in the fridge at 4 °C or used im-
mediatetly. The MFC was then trimmed into 3 cm long test strips
and interfaced with a single 1 ml syringe using a short 3 mm i.d.
Fig. 1. MCFphone system overview. (A) Main components of MCFphone (1) Mi-
crocapillary Film (MCF) (2) Smartphone (3) Magnifying lens (4) Blue LED (5) UV
black light for ﬂuorescence detection, light source for chromogenic detection
(6) dichroic ﬁlter. (B) The Microcapillary Film (MCF), melt extruded from ﬂuori-
nated-ethylene-propylene (FEP) copolymer (i) 5 m MCF reel (ii) MCF cross section
with 10*200 mm embedded in the FEP polymer. (C) MCFphone detection in op-
eration (i) MCFphone components (ii) MCFphone colorimetric image of a sample
and a reference strips ﬁlled up with 2,3-diaminophenazine (DAP), the product of
HRP conversion of o-Phenylenediamine dihydrochloride.
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multi-syringe aspirator; this semi-automatic device allows 8 test
strips and a total of 80 capillaries to be ﬁlled simultaneously using
a set of 1 ml plastic syringes with minimum training as described
elsewhere (Barbosa et al., 2014).
2.3.2. PSA sandwich assay
The PSA sandwich assay consisted in pre-loading 150 ml of
sample and immunoassay reagents into each well in microplate
especially designed to interface the MCF strips. The test strips
were then immersed in microplate wells and solutions aspirated
sequentialy by manually moving the piston plunger of the dis-
posable syringe as illustrated in Fig. 2A. In all experiments shown
in this paper 8 MCF strips were operated simultaneously based on
the multi-syringe aspirator, which is capable of runing a 7 pointfull response curve plus a control or analysing multiple samples
simultaneously. From the perspective of end use, it only requires
rotating the knob that controls the position of the piston plungers
in the array of 1 ml disposable syringes and moving the device
along a multiplexed microplate containing all pre-loaded reagents.
On each incubation step, about 78 μl of solution are aspirated
corresponding to 6 full rotations of the knob. With this design, the
total number of steps required to complete the PSA sandwich
immunoassay was reduced to 5, and all waste solutions were kept
inside the 1 ml disposable syringes throughout the assay. The in-
cubation times used for PSA immunoassay are summarised in
Table 1. The concentration of biotinylated detection antibody was
1 mg/ml and PSA recombinant protein standards were diluted in
PBS or whole blood where appropriate.
For colorimetric detection, 1 mg/ml solution of high sensitivity
streptavidin-HRP was used for enzymatic ampliﬁcation, and the
chromogenic substrate consisted of 4 mg/ml OPD and 1 mg/ml
H2O2. Smartphone microphotographies of the MCF strips were
taken with a iPhones 4S at 20 sec interval for a total of 2 min after
addition of the enzymatic substrate. For ﬂuorescence detection,
2 mg/ml of alkaline phosphatase was diluted in carbonate buffer
50 mM, pH 8, and the ﬂuorescence enzymatic substrate consisted
in 0.25 mM solution of ﬂuorescent substrate FDP; the MCF strips
were photographed at 60 sec interval for a total of 10 min. On both
colourimetric and ﬂuorescence assays, the MCF strips were ex-
tensively washed with PBS-Tween before aspirating the enzymatic
substrate.
2.4. Colorimetric and ﬂuorescence detection
Accurate quantitation with smartphone cameras demands
control of environment light (Oncescu et al., 2013), once the ex-
posure time of the camera is automatically adjusted in response to
the amount of light passing through the detection region (Lee
et al., 2014). In order to control environmental light during col-
orimetric detection a small polyethylene box and a blue LED, with
peak 450 nm emission (absorption peak for DAP) were set to-
gether. The blue LED was placed so that the light penetrated along
the length of the channels rather than across them. However, even
with the external environment light control, the light passing
through the detection region was not always consistent due to
different absorbance of the samples. To eliminate the effect of
different exposure times of the camera, all smartphone images
were taken with a reference MCF strip (Fig. 1B (i)) loaded with the
ﬁnal product of enzymatic conversion; the signal from this
strip was then further used for data normalisation as detailed in
Section 2.5.
To test for sensitivity of smartphone detection, MCF strips were
ﬁlled with the chromogenic substance 2, 3-diaminophenazine
(DAP, resulting from OPD enzymatic substrate conversion) in 1:2
serial dilution in distilled water, from 0.074 to 9.5 mM and imaged
with the MCFphone. Sensitivity of the detection system was cal-
culated by analysing the grey scale in the microphotographs of the
MCF strips and adding 3 times the blank standard deviation to the
blank value. This gives the minimum absorbance value detectable
with the colorimetric setup, therefore setting the sensitivity of the
system.
Fluorescence quantitation was carried out in the dark using an
Ultraviolet Mini Lantern UV to excite the ﬂuorescence product in
the microcapillaries. The UV light was placed under a mask with
an aperture sufﬁcient to place both the MCF strip sample and re-
ference. The MCF strips were then overlap with a green dichroic
additive ﬁlter allowing only the green colour (530 nm) to pass
through and be capture by the smartphone placed on the top of
the ﬁlter.
Sensitivity of ﬂuorescence detection mode was tested by ﬁlling
Fig. 2. PSA sandwich assay with MCFphone signal quantitation. (A) PSA sandwich assay steps. (B) Colorimetric signal quantitation (i) RGB and green channel image (1 mg/
ml) with reference strip (0.5 mg/ml) of 2,3-diaminophenazine (DAP) (ii) Correspondent grey scale analysis. (C) Fluorescence signal quantitation (i) RGB and green channel
image (0.5 mM of ﬂuorescein isothiocyanate, FITC, with reference strip of 0.125 mM) (ii) Correspondent grey scale analysis.
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thiocyanate (FITC) in distilled water in the 7.8 to 500 mM con-
centration range. The strips were placed in the dark metal support
according to ﬂuorescence MCFphone detection setup andsmartphone photographs recorded. In the same way to colori-
metric system sensitivity, ﬂuorescence sensitivity was calculated
by adding 3 times the blank standard deviation to the blank after
image analysis.
Table 1
Incubation times comparison between PSA colorimetric assay and ﬂuorescence
assay.
Incubation Times (min)
PSA colour assay PSA ﬂuorescent assay
Sample/PSA standard 2 2
Detection Antibody 5 5
Enzyme-complex 5 5
Enzymatic substrate 1 10
Total Assay Time 13 22
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The iPhones 4S images were analysed with ImageJ software,
and consisted in splitting the acquired RGB images into Red, Green
and Blue (RGB) channels for both colorimetric and ﬂuorescence
detection modes. For colorimetric quantitation, the absorbance
(Abs) was calculated from the mean pixel intensity in grey scale in
the green channel as shown in Fig. 2B (i) based in Eq. (1), where I0
is the mean grey scale intensity of the baseline and I is determined
based on the difference between the baseline and the maximum
grey scale peak height, h as seen in Eq. (2) (Fig. 2C (ii)). The mi-
crocapillaries in the MCF have a circular to elliptical geometry,
therefore the transmittance images have a minimum grey scale
intensity at the centre of the capillaries where the light path dis-
tance is maximum. The Abs value presented for each MCF sample
studied is a mean Abs value calculated by averaging the whole
array of 10 individual microcapillaries in each MCF strip. The Abs
value for each strip was further normalised based on the Abs value
of the reference strip in order to compensate for the automatic
settings of the smartphone camera, yielding the Absorbance ratio,
Absratio shown in Eq. (3).
⎛
⎝⎜
⎞
⎠⎟Abs
I
I
log
(1)10 0
= −
I I h (2)0= −
Abs Ratio
Abs
Abs (3)
sample i
ref
,=
For ﬂuorescence quantitation in the MCFphone, the split green
channel image (Fig. 2C (i)) was used to produce a grey scale plot
from where the ﬂuorescence intensity, Iint was measured for each
individual microcapillary in the MCF strips (Fig. 2C (ii)). The
intensity of the peaks for each capillary was then normalised by
the mean intensity peak of the reference strip, Iint,ref thus elim-
inating variability of camera exposure settings. Consequently,
ﬂuorescence signal is presented as an average of ﬂuorescence
intensity ratio (ﬂuorescence ratio) of the 10 capillaries in each MCF
strip (Eq. (4)).
Fluorescence ratio
I
I (4)
int sample
int ref
,
,
=
The LoD was determined as the minimum concentration
yielding a signal higher than the blank value plus 3 times the
standard deviation of the blank. When appropriate this value was
calculate using a 4PL (4 parameter logistic model) best-ﬁtted to
the experimental response curve.
2.6. Recovery PSA experiments from whole blood samples
%Recovery was calculated for three different anticoagulated
fresh whole blood samples (samples S1, S2 and S3) spiked with0.74, 6.7 and 60 ng/ml of PSA recombinant protein. Fluorescence
intensity was then determined in the MCFphone for the different
blood samples using procedure described in Section 2.5. The %
Recovery was calculated based on the ratio of the Abs or ﬂuores-
cence signal in assay buffer to the signal in the blood sample in
percentage basis. A iPhones 5s was used to microphotograph the
MCF test strips.3. Results and discussion
3.1. Sensitivity of MCFphone for detection of chromogenic and che-
miﬂuorescence substrates
Optical detection based on simple and cost-effective technol-
ogies like a smartphone demands speciﬁc optical properties from
the assay platform to be able to use small changes in transmitted
light intensity for analyte quantitation. The MCF ﬂuoropolymer has
special optical properties, such as high degree of transparency
obtained by a matched refractive index of FEP material with an
aqueous sample, combined with the ﬁlm ﬂat geometry that
minimises light diffraction, reﬂection or scattering (Edwards et al.,
2011). This favours sensitive immunoassays that combined with
short diffusion distances yields a powerful miniaturised and por-
table POC immunoassay concept.
Colorimetric detection is inherently less sensitive than ﬂuor-
escence, due to fundamental limitations of colorimetry itself. From
one hand, in order to measure low concentrations of a chromogen,
small differences in intensity must be measured at high light in-
tensity, which limits the LoD. On the other hand, relationship
between optical Abs and intensity of transmitted light is loga-
rithmic. Therefore, at high chromogen concentrations relatively
large differences in optical absorbance correspond to small dif-
ferences in the intensity of unabsorbed light, which usually
corresponds to narrow dynamic range for immunoassays (Gosling,
1996). However, colorimetric detection is still widely used in im-
munoassays, offering speed, simplicity, well established assay
chemistry and high quality reagents, and widespread availability
of cost-effective readers. For this reason researchers still focused in
ﬁnding new ways to increase the performance of colorimetric
detection, for example through enzymatic ampliﬁcation systems
(Brooks et al., 1991; Gao et al., 2014). Besides being inherently less
sensitive, colorimetric detection sensitivity can also be limited by
the working range of the instrument.
In our recent study, we have measured PSA in biological sam-
ples in less than 15 min using a ﬂatbed scanner (Barbosa et al.,
2014). In this study we aimed turning the “Lab-in-a briefcase”
power-free, by using a portable detection system. Understanding
the sensitivity and dynamic range of colorimetric measurement
using the MCFphone setup is therefore fundamentally important,
since performance for absorbance measurement will limit the
working range and sensitivity of MCF immunoassays. As a
benchmark, a spectrophotometer was used to measure a range of
concentrations of DAP, the chromogenic product of enzymatic
conversion of the substrate OPD commonly used in enzyme-linked
immunosorbent assays (ELISA). At the peak absorption of 425 nm
(Fig. 3A), the spectrophotometer has a LoD ofo2.3 mM of DAP
(Fig. 3B). In contrast, the MCFphone sensitivity for DAP measure-
ment was 148 mM (Fig. 3C), i.e. 2 orders of magnitude less sensitive
than a sophisticated spectrophotometer with a 1 cm thick cuvette.
This drop in sensitivity can be accounted for by the broad wave-
lengths measured of RGB system, compared to the speciﬁc narrow
wavelength selection in a spectrophotometer. Also, the MCFphone
presents a 50-fold reduction in the light path when compared to
the spectrophotometer cuvette, which reduces the absolute ab-
sorbance for any concentration of a chromogen.
Fig. 3. Sensitivity of MCFphone for colorimetric and ﬂuorescence detection. (A) Absorption spectrum of 2,3-diaminophenazine (DAP). (B) Sensitivity of spectrophotometer
DAP relative. (C) MCFphone chromogenic sensitity determination (DAP serial dilution). (D) MCFphone ﬂuorescence sensitivity determination (ﬂuorescein isothiocyanate,
FITC serial dilution).
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measurement for colorimetric substrates, however they are not
suitable for POC. Clinical relevant sensitivities from colorimetric
portable detection system must therefore be achieved by assay
optimisation, for example using enzymatic ampliﬁcation, as pre-
viously observed in ELISA systems, and as demonstrated in the PSA
assay results presented in this paper.
Fluorescence detection systems are characteristically more
sensitive once they are measured relatively to an absence of light
(Gosling, 1996). The MCF phone ﬂuorescence calibration curve,
presented a dynamic range of 7.8–500 mM for FITC and a LoD be-
low 7.8 mM (Fig. 3D). The ﬂuorescence detection system selected
for further study with PSA immunoassays uses UV light which
emits radiation between 340 and 400 nm to excite ﬂuorescein to
emit green light at 530 nm. Although this reduces the absorbance
efﬁciency compared to excitation at the peak absorbance of
around 480 nm, this system exploits a large stokes shift resulting
in a large increase from excitation to emission wavelength, thuseliminating the interference of the incident light with the image
acquired by the smartphone which is very insensitive to UV light.
This system does not require the use of an expensive bandpass
ﬁlter, further increasing the simplicity of the optics. Combined
with a good quantum efﬁciency ﬂuorescein is an attractive sub-
strate (Weeks and Kricka, 2013).
The MCFphone achieved similar sensitivity with ﬂuorescence
detection to absorbance measurement in the bench-top spectro-
photometer, allowing sensitive and portable measurement and
justifying the use of ﬂuorescence detection in microﬂuidic im-
munoassays (Darain et al., 2009; Lin et al., 2010). The MCFphone is
a ﬂexible detection system, with a choice of rapid colour detection
or sensitive ﬂuorescence detection that can be selected to suit
different applications.3.2. Effect of detection mode on sensitivity of PSA sandwich ELISA in
Fig. 4. PSA full response curves in buffer, with MCFphone colorimetric and ﬂuorescence systems. (A) PSA MCFphone colorimetric quantitation: (i) RGB and green channel
digital images, and (ii) full response curve, showing a lower limit of detection, LoDo0.9 ng/ml PSA. (B) PSA MCFphone ﬂuorescence quantitation: (i) RGB and green channel
digital images, and (ii) full response curve with LoD clearly below 0.9 ng/ml of PSA.
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Enzymes are the most versatile and common group of labelling
substances used in immunoassays (Gosling, 1996). Macro-
molecules are measurable at very low concentrations typically in
the picomolar to femtomolar range by utilising its catalytic prop-
erties to generate coloured, ﬂuorescent, or luminescent com-
pounds from a neutral substrate. A single enzyme molecule may
cause the conversion of 107 molecules of substrate per minute,
increasing the strength of the signal and therefore the sensitivity
by a million-fold when compared to a label that produces just a
signal event (Weeks and Kricka, 2013). When enzymes are asso-
ciated with antibodies in sandwich immunoassays, the most spe-
ciﬁc and sensitive type of heterogeneous immunoassays (Chris-
topoulos, 1996), a powerful analytical tool is produced.
Although the colorimetric substrate measurement in the
MCFphone was about 2 orders of magnitude less sensitive than the
benchtop spectrophotometer, this system was still able to quantify
PSA in its clinical relevant range (i.e. a clinical threshold of 44 ng/
ml requiring further examination) with LoD of 0.9 ng/ml PSA
(Fig. 4A) in 13 min total assay time (Table 1). Reaction time is
important for POC applications, where quick tests are required.
In conventional microtiter plate based ELISA high sensitivity is
achieved using long incubation times and long assay times, how-
ever kinetic studies in MCF platform showed that is possible to
achieve high sensitivity with short incubation times and that long
incubation times will actually increase the background decreasing
sensitivity. Therefore, short incubation times favoured higher sig-
nal-to-noise-ratios in the PSA immunoassay.
Despite previous optimisation of PSA assay, the best sensitivity
was achieved by combining a sandwich heterogeneous assay for-
mat with a horseradish peroxidase (HRP) label. HRP has a highturnover number and due to short diffusion distance of capillaries
it was possible to increase the OPD substrate concentration and
optimise the molar ratio of OPD to H2O2 contributing to faster and
higher signal ampliﬁcation and compensating for the lower sen-
sitivity of colorimetric MCFphone readout.
Fluorescence measurement using the MCFphone gave greater
sensitivity than colorimetric, achieving similar LoD to the bench-
top spectophometer. This increased sensitivity resulted in even
greater assay sensitivity when a full PSA response curve was tested
(Fig. 4B) and a LoD of 0.08 ng/ml PSA was achieved. The increased
sensitivity of the assay can be attributed to ﬂuorescence detection
combined with other factors including the alkaline phosphatase
label that like HRP has high enzymatic turnover and the ability of
the ﬂuorogenic product (ﬂuorescein) to absorb UV radiation
around 380 nm and emit green radiation around 530 nm, which
was enhanced with the use of the dichroic additive green ﬁlter.
Although ﬂuorescence detection increased sensitivity, the
ﬂuorogenic substrate incubation time was longer than the chro-
mogenic substrate incubation time (Table 1), due to differences in
reaction rates of the two enzymes. Further optimisation may be
required to reduce the overall assay time, and previous work with
HRP has demonstrated the improvements to assay time and sen-
sitivity that are possible with systematic assay optimisation in
MCF immunoassays (Barbosa et al., 2014).
Similar studies measured PSA with a microﬂuidic device in-
corporating colorimetric smartphone detection, and reported
3.2 ng/ml PSA as the LoD in 30 min total assay time using magnetic
microbeads (Adel Ahmed and Azzazy, 2013), thus a 3.5 lower
sensitivity for double of the assay time compared to the
MCFphone.
Fluorescent measurements performed with the immuno-pillar
microﬂuidic platform reported a LoD of 0.1 ng/ml in 12 min total
A.I. Barbosa et al. / Biosensors and Bioelectronics 70 (2015) 5–1412assay time, which means similar sensitivity, but double of time for
ﬂuorescence detection on MCFphone. However, it is important to
emphasise that the detection equipment used to quantify PSA in
the immuno-pillar platform was an inverted ﬂuorescence micro-
scope, which is not portable, cost-effective or power-free, there-
fore not suitable for POC applications (Ikami et al., 2010). An im-
munochromatographic test integrated with a Laser Fluorescence
Scanner was able to detect PSA in biological samples with a lower
limit of detection of 0.02 ng/ml PSA in 15 min total assay time (Oh
et al., 2009). This assay was able to obtain better sensitivity than
the MCFphone in less time. Nevertheless, lateral ﬂow tests have
certain limitation compared with microﬂuidic devices, for example
they lack the possibility to perform calibration curves in simulta-
neous with the samples (Posthuma-Trumpie et al., 2009), which
can be an important feature for biomarker quantitation at POC.
Besides the drawbacks of lateral ﬂow technology, the Laser
Fluorescence Scanner is not as ﬂexible as a smartphone, once it
can be used for colorimetric detection, for data analysis and for
results communication all in one single power-free and portableFig. 5. Smartphone ﬂuorescence detection of PSA in the MCF in whole blood. (A) Full res
in buffer and 50% whole blood. (C) %Recovery for 3 different blood samples from female
60 ng/ml.device, which is quickly becoming a cost-effective equipment. In
addition, this is the ﬁrst time to our knowledge that a smartphone
is used to quantify ﬂuorescence in a sandwich ELISA assay.
3.3. PSA measurement in whole Blood samples
In POC testing, sample processing needs to be minimised or
eliminated to speed up the diagnostic process (von Lode, 2005) so
whole blood samples are preferred. However, whole blood has one
of the most complex matrices, with interference possible due to
serum proteins that can bind non-speciﬁcally to analytes, anti-
bodies or surfaces (Chiu et al., 2010). This biological ﬂuid also
presents a high viscosity that can alter the binding efﬁciency
(Morgan et al., 1998) and the diffusion time of the analyte to the
immobilised antibody. Signiﬁcant work has been published de-
scribing methods to overcome the effect of biological matrices in
order to achieve robust assay sensitivity and reproducibility in
other laboratory and POC assay platforms (Chiu et al., 2010). Ma-
trix effects are system speciﬁc, depending on matrix type,ponse curve using 1:3 dilution series. (B) Comparison between PSA sandwich assay
donors spiked with 3 different concentrations of recombinant protein, 0.74, 6.7 and
Table 2
Sensitivity comparison between MCFphone colorimetric and ﬂuorescence PSA assay.
Lowest PSA conc. tested (ng/ml) Data correlation with 4PL model (R2) LoD (ng/ml) Precision
PSA colour assay 0.9 0.9979 0.40 7% at 15 ng/ml PSA
PSA ﬂuorescent assay 0.9 0.9933 0.08 8% at 15 ng/ml PSA
PSA ﬂuorescent assay in whole blood 0.08 0.9978 0.04 11% at 2.2 ng/ml PSA
A.I. Barbosa et al. / Biosensors and Bioelectronics 70 (2015) 5–14 13detection method, antibody system and platform. The matrix ef-
fect has already been reported by our research group for sandwich
ELISA detection of PSA in whole blood in the MCF platform using a
ﬂatbed scanner readout system (Barbosa et al., 2014). From these
studies we concluded that PSA could be accurately quantiﬁed in
whole blood samples in the MCF platform. However, non-diluted
whole blood matrices did show lower signals for the same in-
cubation times as buffer matrices. This signal reduction could be
overcome either by dilution or by extended sample incubation
times. As the aim of this work is to create a rapid POC diagnostic
system, sample dilution was chosen here instead of extended
sample incubation times to maintain the sensitivity and reprodu-
cibility of PSA assay in biological samples and restrict total assay
time. Sample dilution is often used in serology and does not re-
present an additional step in the assays, as the sample wells can be
provided with diluent buffer.
In this study, the MCFphone ﬂuorescence detection system was
used to quantify PSA from diluted whole blood (Fig. 5). The sen-
sitivity calculated and assay signal were in the same order of
magnitude (Fig. 5A and Table 2) when compared to the assay
performed in buffer across all the PSA assay range (Fig. 5B). Fur-
ther experiment using whole blood from 3 additional patients
showed a %Recovery very consistent when spiked with PSA con-
centration in the low linear range (0.74 ng/ml), middle range
(6.7 ng/ml) and higher linear range (60.0 ng/ml). In all cases, %
Recovery values calculated for the different whole blood samples
remained within 80–120%, which is regarded as the desirable
range, with the exception of S2 spiked with 60.0 ng/ml of PSA
which returned 76.3%. This ultimately demonstrates the
MCFphone as an efﬁcient PSA measurement system from fresh
anticoagulated whole blood samples, simplifying sample pre-
paration required for clinical testing. Future studies will aim un-
derstanding blood matrix effect on variability between samples,
and test the MCFphone with patients diagnosed with prostate
cancer.4. Conclusions
The MCFphone is a ﬂexible, power-free and portable im-
munoassay detection system capable of rapid colorimetric detec-
tion and sensitive ﬂuorescence detection from whole blood sam-
ples. In this present study, the MCFphone was able to detect and
quantify PSA within the dynamic range of 0.9 to 60 ng/ml PSA in
13 min, using colorimetric detection and within 0.08 ng/ml to
60 ng/ml of PSA, using ﬂuorescence detection from whole blood
samples. Considering the PSA clinical range of 4 ng/ml for prostate
biopsy, this device can provide reliable measurements for prostate
cancer screening and detection in remote areas outside laboratory
facilities. Further improvements in ﬂuorescence sensitivity could
be obtained with optimisation of enzymatic reaction, a more ro-
bust and intense UV light source and ﬁlters, as well as higher re-
solution smartphone cameras. Automation of multistep ELISA and
further integration and miniaturisation of all ﬂuidic and optoe-
lectronics components will addressed in future publications with
the MCFphone concept.Conﬂict of interest
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